Hong Kong and Macau on March 24 temporarily suspended the use of the Pfizer-BioNTech coronavirus vaccine after a batch was found with packaging defects. According to South China Morning Post (SCMP), the Hong Kong government announced the cancellation of bookings at all 21 community vaccination centres providing the German-made jab “until further notice”. Macau and Hong Kong reportedly said that their decision to suspend the Pfizer vaccine came after they were contacted about the issue by Fosun, the Chinese pharmaceutical company that is distributing the BioNTech vaccine in China.
